- Home
- BBAR vs PTGX Comparison
BBAR vs PTGX Comparison
Compare BBAR & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBAR
- PTGX
- Stock Information
- Founded
- BBAR 1886
- PTGX 2006
- Country
- BBAR Argentina
- PTGX United States
- Employees
- BBAR N/A
- PTGX N/A
- Industry
- BBAR Commercial Banks
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- BBAR Finance
- PTGX Health Care
- Exchange
- BBAR Nasdaq
- PTGX Nasdaq
- Market Cap
- BBAR 3.4B
- PTGX 3.3B
- IPO Year
- BBAR N/A
- PTGX 2016
- Fundamental
- Price
- BBAR $16.28
- PTGX $50.65
- Analyst Decision
- BBAR Buy
- PTGX Strong Buy
- Analyst Count
- BBAR 1
- PTGX 9
- Target Price
- BBAR $27.00
- PTGX $67.11
- AVG Volume (30 Days)
- BBAR 645.6K
- PTGX 969.4K
- Earning Date
- BBAR 08-20-2025
- PTGX 08-05-2025
- Dividend Yield
- BBAR 6.12%
- PTGX N/A
- EPS Growth
- BBAR 9.91
- PTGX N/A
- EPS
- BBAR 0.57
- PTGX 0.86
- Revenue
- BBAR $2,595,064,489.00
- PTGX $207,801,000.00
- Revenue This Year
- BBAR N/A
- PTGX N/A
- Revenue Next Year
- BBAR $35.30
- PTGX $47.15
- P/E Ratio
- BBAR $9.01
- PTGX $57.63
- Revenue Growth
- BBAR N/A
- PTGX N/A
- 52 Week Low
- BBAR $7.05
- PTGX $32.50
- 52 Week High
- BBAR $25.01
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- BBAR 40.81
- PTGX 45.62
- Support Level
- BBAR $15.35
- PTGX $49.38
- Resistance Level
- BBAR $16.54
- PTGX $51.51
- Average True Range (ATR)
- BBAR 0.68
- PTGX 1.97
- MACD
- BBAR 0.03
- PTGX -0.81
- Stochastic Oscillator
- BBAR 42.24
- PTGX 16.17
About BBAR Banco BBVA Argentina S.A. ADS
Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focuses on foreign trade, agricultural business, and digital products.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.